Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

W. Takayama; T. Asano; S. Kobayashi; S. Nakagouri; T. Kenmochi; S. Okazumi; A. Takeda; T. Fukunaga; K. Iwasaki; K. Shutou; H. Matsuzaki; H. Aoyama; K. Shinotou; T. Kouno; K. Isono

Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

W. Takayama
, T. Asano
, S. Kobayashi
, S. Nakagouri
, T. Kenmochi
, S. Okazumi
, A. Takeda
, T. Fukunaga
, K. Iwasaki
, K. Shutou
, H. Matsuzaki
, H. Aoyama
, K. Shinotou
, T. Kouno
, K. Isono

Research output: Contribution to journal › Article › peer-review

Abstract

For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.

Original language	English
Pages (from-to)	867-871
Number of pages	5
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	25
Issue number	6
Publication status	Published - 05-1998
Externally published	Yes

All Science Journal Classification (ASJC) codes

General Medicine

Cite this

Takayama, W., Asano, T., Kobayashi, S., Nakagouri, S., Kenmochi, T., Okazumi, S., Takeda, A., Fukunaga, T., Iwasaki, K., Shutou, K., Matsuzaki, H., Aoyama, H., Shinotou, K., Kouno, T., & Isono, K. (1998). Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE). Gan to kagaku ryoho. Cancer & chemotherapy, 25(6), 867-871.

@article{599c673905004f11a3b8301d0281a6de,

title = "Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)",

abstract = "For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.",

author = "W. Takayama and T. Asano and S. Kobayashi and S. Nakagouri and T. Kenmochi and S. Okazumi and A. Takeda and T. Fukunaga and K. Iwasaki and K. Shutou and H. Matsuzaki and H. Aoyama and K. Shinotou and T. Kouno and K. Isono",

year = "1998",

month = may,

language = "English",

volume = "25",

pages = "867--871",

journal = "Gan to kagaku ryoho. Cancer \& chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "6",

}

Takayama, W, Asano, T, Kobayashi, S, Nakagouri, S, Kenmochi, T, Okazumi, S, Takeda, A, Fukunaga, T, Iwasaki, K, Shutou, K, Matsuzaki, H, Aoyama, H, Shinotou, K, Kouno, T & Isono, K 1998, 'Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 25, no. 6, pp. 867-871.

TY - JOUR

T1 - Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

AU - Takayama, W.

AU - Asano, T.

AU - Kobayashi, S.

AU - Nakagouri, S.

AU - Kenmochi, T.

AU - Okazumi, S.

AU - Takeda, A.

AU - Fukunaga, T.

AU - Iwasaki, K.

AU - Shutou, K.

AU - Matsuzaki, H.

AU - Aoyama, H.

AU - Shinotou, K.

AU - Kouno, T.

AU - Isono, K.

PY - 1998/5

Y1 - 1998/5

N2 - For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.

AB - For 6 patients with advanced hepatocellular carcinoma (HCC) in whom TAE was inefficacious, we tried hepatic arterial infusion chemotherapy. 5-FU 500 mg/day + CDDP 10 mg/day was administered during 5 days. The AFP level was decreased for 4 patients, and 2 patients showed a partial response in CT image. These 2 patients have been alive over 22 and 18 months, respectively. These results suggest that 5-FU + CDDP HAI might be a useful treatment of HCC inefficacious with TAE.

UR - https://www.scopus.com/pages/publications/0032059093

UR - https://www.scopus.com/pages/publications/0032059093#tab=citedBy

M3 - Article

C2 - 9617325

AN - SCOPUS:0032059093

SN - 0385-0684

VL - 25

SP - 867

EP - 871

JO - Gan to kagaku ryoho. Cancer & chemotherapy

JF - Gan to kagaku ryoho. Cancer & chemotherapy

IS - 6

ER -

Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this